Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Hlavní autoři: | Rocca, B, Buck, G, Petrucci, G, Parish, S, Pagliaccia, F, Baigent, C, Mafham, M, Bowman, L, Armitage, J, Patrono, C |
---|---|
Další autoři: | The ASCEND Study Collaborative Group |
Médium: | Conference item |
Jazyk: | English |
Vydáno: |
Oxford University Press
2020
|
Podobné jednotky
-
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
Autor: Petrucci, G, a další
Vydáno: (2024) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Autor: Parish, S, a další
Vydáno: (2023) -
Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Autor: Aung, T, a další
Vydáno: (2017) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Autor: Sarah Parish, a další
Vydáno: (2023-03-01) -
Measurement of Thromboxane Biosynthesis in Health and Disease
Autor: Carlo Patrono, a další
Vydáno: (2019-10-01)